Mar 4, 2022 This Week in Cardiology

Mar 4, 2022 This Week in Cardiology

An update to CardioMEMs post, ARBs and cancer, troponins, empagliflozin, and low-value care are the topics discussed by John Mandrola, MD, in this week's podcast.

This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic

I – Invasive Monitoring for HF

- FDA Expands Eligibility for CardioMEMS Heart Failure System https://www.medscape.com/viewarticle/969004

- Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial https://doi.org/10.1016/S0140-6736(21)01754-2

II – ARBs and Cancer

- ARBs and Cancer Risk: New Meta-Analysis Raises Questions Again https://www.medscape.com/viewarticle/969510

- Risk of cancer with angiotensin-receptor blockers increases with increasing cumulative exposure: Meta-regression analysis of randomized trials https://doi.org/10.1371/journal.pone.0263461

- Marciniak Meta-analysis in FDA Medical Review 206316Orig1Orig2s000 https://rb.gy/myhlvy

III – Troponins and Cardiac Surgery

- What Troponin Level Indicates Injury After Cardiac Surgery? https://www.medscape.com/viewarticle/969617?src=

- High-Sensitivity Troponin I after Cardiac Surgery and 30-Day Mortality https://www.nejm.org/doi/full/10.1056/NEJMoa2000803

- Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease https://www.nejm.org/doi/full/10.1056/nejmoa1909406

IV – Empagliflozin in HFpEF

- FDA Okays Empagliflozin for HF Regardless of Ejection Fraction https://www.medscape.com/viewarticle/969118

- Empagliflozin in Heart Failure with a Preserved Ejection Fraction https://www.nejm.org/doi/full/10.1056/NEJMoa2107038

- Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://www.nejm.org/doi/full/10.1056/NEJMoa1908655

V – Low-Value Care

- AHA Targets 'Low-Value' Heart Care in New Scientific Statement https://www.medscape.com/viewarticle/969107

- Strategies to Reduce Low-Value Cardiovascular Care: A Scientific Statement From the American Heart Association https://www.ahajournals.org/doi/abs/10.1161/HCQ.0000000000000105

You may also like:

Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine https://www.medscape.com/features/public/machine

The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington

Questions or feedback, please contact news@medscape.net

Jaksot(387)

Nov 8, 2019 This Week in Cardiology Podcast

Nov 8, 2019 This Week in Cardiology Podcast

Words that harm, statins, thyroid replacement, and the ISCHEMIA trial are the topics discussed by Dr John Mandrola in this week's podcast.

8 Marras 201922min

Nov 1, 2019 This Week in Cardiology Podcast

Nov 1, 2019 This Week in Cardiology Podcast

Mortality after AF ablation, cardiac rehab programs, hypertrophic cardiomyopathy, and clinician wellness are the topics Dr. John Mandrola discusses in this week's podcast.

1 Marras 201919min

Oct 25, 2019 This Week in Cardiology Podcast

Oct 25, 2019 This Week in Cardiology Podcast

AF after TAVR, opioids after cardiac devices, hypertension in black adults, and post-cardiac surgery AF are the topics Dr John Mandrola discusses in this week's podcast.

25 Loka 201917min

Oct 18, 2019 This Week in Cardiology Podcast

Oct 18, 2019 This Week in Cardiology Podcast

The Nobel Prize, more on the EXCEL trial, the costs of cardiac tests, familial hypercholesterolemia, and burnout are the topics discussed by Dr John Mandrola in this week's podcast.

18 Loka 201919min

Oct 11 2019 This Week in Cardiology

Oct 11 2019 This Week in Cardiology

Left main PCI vs CABG trials and TAVR vs SAVR—in this week's podcast, Dr John Mandrola takes a deeper dive.

11 Loka 201927min

Sep 27, 2019 This Week in Cardiology Podcast

Sep 27, 2019 This Week in Cardiology Podcast

Social effects of medicine, SGLT2 inhibitors, CIED infections, equity in cardiology, and post-PCI anti-thrombotic therapy are the topics discussed by Dr John Mandrola in this week's podcast.

27 Syys 201916min

Sep 20, 2019 This Week in Cardiology Podcast

Sep 20, 2019 This Week in Cardiology Podcast

The polypill, dapagliflozin, TAVR, and video games are discussed by John Mandrola, MD, in this week's podcast.

20 Syys 201918min

Sep 13, 2019 This Week in Cardiology Podcast

Sep 13, 2019 This Week in Cardiology Podcast

More from ESC: Antiplatelets and NOACs, blood glucose control, high sensitivity troponin tests, and ICD trials are all covered by John Mandrola, MD, in this week's podcast.

13 Syys 201923min

Suosittua kategoriassa Tiede

rss-mita-tulisi-tietaa
utelias-mieli
tiedekulma-podcast
docemilia
rss-duodecim-lehti
rss-poliisin-mieli
mielipaivakirja
rss-radplus
radio-antro
rss-tiedetta-vai-tarinaa
rss-tervetta-skeptisyytta
filocast-filosofian-perusteet
menologeja-tutkimusmatka-vaihdevuosiin
rss-kasvatuspsykologiaa-kaikille
rss-politiikasta-podcast
rss-laakaripodi
rss-ilmasto-kriisissa
rss-taivaanranta
rss-taivaantarkkailijan-tarinoita